SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Aptargroup, Inc. (New York Stock Exchange:ATR)

US · Delayed Price · Currency is USD
120.43+0.18 (+0.15%)
 
Market Cap7.69B-8.5%
Revenue (ttm)3.93B+8.9%
Net Income362.52M-7.4%
EPS5.53-4.8%
Shares Out63.82M
PE Ratio21.51
Forward PE19.25
Dividend$1.92(1.59%)
Ex-Dividend DateJul 30, 2026
Volume605,910
Open120.91
Previous Close120.25
Day's Range119.86 - 121.33
52-Week Range103.23 - 146.91
Beta0.34
AnalystsBuy
Price Target155.00(+28.71%)
Earnings DateOct 29, 2026
Insider Score
––Not scored
ATR Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

About ATR

AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.

Address
265 Exchange Drive, Crystal Lake, IL, 60014, US
Market Cap
7.69 billion
Employees
14,000
Industrial Classification
Medical - Instruments & Supplies

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$5.23M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
+0.15%
5 Days
-0.75%
1 Month
-3.14%
6 Months
-8.78%
1 Year
-8.49%

$ATR stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of ATR by members of U.S. Congress

PoliticianTypeTraded
Michael T. McCaulHouse / RSale$1.00K – $15.00KJun 18, 2026
Michael T. McCaulHouse / RPurchase$15.00K – $50.00KJun 12, 2026
Michael T. McCaulHouse / RPurchase$15.00K – $50.00KNov 19, 2025
Michael T. McCaulHouse / RPurchase$15.00K – $50.00KSep 22, 2025
Michael T. McCaulHouse / RPurchase$1.00K – $15.00KSep 11, 2025
Michael T. McCaulHouse / RSale$1.00K – $15.00KAug 26, 2024
Michael T. McCaulHouse / RPurchase$1.00K – $15.00KNov 1, 2023
Michael T. McCaulHouse / RPurchase$15.00K – $50.00KNov 1, 2023

Recently reported changes in ATR holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by ATR's directors and management

Net Shares Purchased by Insiders−30k−15k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

ATR Estimated quarterly lobbying spending

Source: U.S. Senate LDA

ATR Revenue by Segment or Geography

$387.08MTotal
SegmentRevenue% of All
Adjusted EBITDA$228.50M59.03%
Selling, Research & Development and Administrative:$157.74M40.75%
Net unrealized investment gain (loss)$849.00K0.22%

As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New ATR patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to ATR from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in ATR

ETFEst. Holding Size
VTIVanguard Morningstar Total Stock Market ETF$267.20M
VBVanguard Morningstar Small-Cap ETF$193.28M
VBRVanguard Morningstar Small-Cap Value ETF$122.74M
VXFVanguard Extended Market ETF$97.61M
DFATDimensional - US Targeted Value ETF$72.39M
SDYState Street SPDR S&P Dividend ETF$67.49M

Estimated from each fund’s disclosed top holdings × AUM

ATR Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for ATR is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from ATR’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys
0
Sells
15
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.